Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation

Chest

Volumn 114, Issue 2, 1998, Pages 577-586

  Standaert, Thomas A ^a   Morlin, Gregory L ^b   Williams Warren, Judy ^a   Joy, Pamella ^a   Pepe, Margaret S ^c   Weber, Allan ^b   Ramsey, Bonnie W ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b University of Missouri   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Aerosols; Aminoglycosides; Cleaning; Efficiency; Nebulizers; Tobramycin

Indexed keywords

CROMOGLYCATE DISODIUM; GENTAMICIN; SALBUTAMOL; TOBRAMYCIN;

AEROSOL; ANTIBIOTIC THERAPY; ARTICLE; BRONCHODILATATION; CYSTIC FIBROSIS; DEVICE; DISPOSABLE EQUIPMENT; DRUG SELF ADMINISTRATION; ENZYME ACTIVITY; HUMAN; LASER DIFFRACTION; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0031813115     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.2.577     Document Type: Article

References (28)

1. Rosenfeld M, Emerson J, Astley S, et al. Home nebulizer usage among patients with cystic fibrosis. J Pediatr 1998; 132:125-31
2. Smith EC, Denyer J, Kendrick AH. Comparison of 23 nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995; 8:1214-21
3. Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994; 106:1788-1292
4. Waldrep JC, Keyhani K, Black M, et al. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 1994; 105:106-10
5. Newnham DM, Lipworth BJ. Nebulizer performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebulizer delivery system ('Ventstream'). Thorax 1994; 49:762-70
6. Cipolla D, Gonda I, Shire SJ. Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers. Pharm Res 1994; 11:491-98
7. Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulizers. Respir Med 1993; 87:461-65
8. Langford SA, Allen MB. Salbutamol output from two jet nebulizers. Respir Med 1993; 87:99-103
9. Smith D, Erskine D, Steele J, et al. Comparison of nebulizer efficiency for aerosolizing pentamidine. J Pharm Pharmacol 1992; 44:7-9
10. O'Riordan TG, Greco MJ, Perry RJ, et al. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992; 145:1117-22
11. Cameron D, Clay M, Silverman M. Evaluation of nebulizers for use in neonatal ventilator circuits. Crit Care Med 1990; 18:866
12. Newman SP, Pellow PGD, Clay MM, et al. Evaluation of jet nebulizers for use with gentamicin solution. Thorax 1985; 40:671-76
13. Clay MM, Pavia D, Newman SP, et al. Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 1983; 38:755-59
14. Hess D, Fisher D, Williams P, et al. Medication nebulizer performance: effects of diluent volume, nebulizer flow and nebulizer brand. Chest 1997; 110:498-505
15. Hollie MC, Malone RA, Skufca RM, et al. Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. Chest 1991; 100:1339-44
16. Alvine GF, Rodgers P, Fitzsimmons KM, et al. Disposable nebulizers - how reliable are they? Chest 1992; 101:316-19
17. Faurisson F, Dessanges JF, Grimfeld A, et al. Nebulizer performance: AFLM study. Respiration 1995; 62:13-18
18. Diot P, Le Pape A, Boissinot E, et al. Caracterisation par methode isotopique des performances du nebuliser pneumatique NL9 Atomisor pour la production d'aerosols de colistin, tobramycine et amiloride. Rev Mal Respir 1994; 11:573-78
19. Weber A, Morlin G, Cohen M, et al. Effect of nebulizer type and antibiotic concentration on device performance. Pediatr Pulmonol 1997; 23:249-60
20. Hinds WC. Aerosol technology: properties, behavior and measurement of airborne particles. New York: Wiley, 1982
21. Cipolla DC, Clark AR, Chan H-K, et al. Assessment of aerosol delivery systems for recombinant human deoxyribonuclease. S. T. P. Pharma Sciences 1994; 4:50-62
22. Smye SW, Jollie MI, Cunliffe H, et al. Measurement and prediction of drug solvent losses by evaporation from a jet nebuliser. Clin Phys Physiol Meas 1992; 13:129-34
23. Gonda I, Cipolla DC, Shire SJ, et al. A case study in aerosol protein drug development: aqueous solution aerosols of rhD-Nase. Respiratory Drug Delivery IV, International Symposia, School of Pharmacy of Virginia Commonwealth University, Richmond, Va, 1994; 47-53
24. Hung JC, Hambleton G, Super M. Evaluation of two commercial jet nebulizers and three compressors for the nebulization of antibiotics. Arch Dis Child 1994; 71:335-38
25. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulizers. Arch Dis Child 1992; 67:586-91
26. McCallion ONM, Taylor KMG, Bridges MPA, et al. Jet nebulizers for pulmonary drug delivery. Int J Pharm 1996; 130:1-11
27. McCallion ONM, Taylor KMG, Thomas M, et al. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm Res 1995; 12:1682-88
28. Hutchinson GR, Parker S, Pryor JA, et al. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, Gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996; 34:584-87